How does survivorship research fit into the cancer control continuum?
Up until 20 years ago, the medical community defined as cancer survivors only those individuals who remained disease free for at least 5 years after treatment – survivorship wasn’t even on the radar screen. But today, clinicians and researchers recognize that life after cancer brings its own unique challenges. Perhaps even more critically, many are also beginning to realize that the continuum of cancer care and control, while often portrayed as a straight line (from prevention to detection, treatment, survivorship, and end of life), is for most survivors, a cyclical process. What are some of the disparities among cancer survivors? As survivorship research expands, we are quickly learning that cultural and sociodemographic factors can differentially affect not just who survives cancer, but importantly, what their survivorship experience is like. For example, research suggests that African American survivors of childhood acute lymphoblastic leukemia are at higher risk of early cardiotoxi
Related Questions
- A few researchers in my institution are interested in becoming research partners on Cancer Control P.L.A.N.E.T. What are the criteria for being listed as a research partner?
- Which Korean American churches can best assist in cancer prevention and control research?
- How does the Center for Cancer Research fit into the National Cancer Institute?
